Aggregated price index with volume information
- Pot stocks down 0.1% on average while median return down 0.1% in a day
- Pot stocks down 2.8% on average while median return down 2.3% in a week
- Pot stocks up 13.4% on average while median return up 4.4% in a month
- When average return is significantly different from median return, this implies an asymmetry - composite return is driven by some outliners.
Aggregated price index (close) is based on equal weighted constituencies returns. Average short volume and average total volumes are averaged across all volume data among constituencies.
- 1M winners are : Winners for past month are $YOLO 20.8%, $CNBS 16.5%, $SNDL 14.5%, $MJ 13.0%, $CRON 7.0%
- 1M losers are : Losers for past month are $POTX -1.9%, $TOKE -3.9%, $TLRY -10.2%, $OGI -13.7%
- 1W winners are : Winners for past week are $CNBS 1.0%
- 1W losers are : Losers for past week are $THCX -2.4%, $YOLO -2.9%, $MJ -3.4%, $CRON -3.8%, $OGI -12.0%
Index correlation analysis
Correlation for the past month is 66.4%, for the past 3 months is 58.4%
In the past month for a 5 days rolling window, the highest corrrelation is 80.9%, the lowest correlation is 37.5%, the latest correlation is 45.2%
When a correlation deviated from the normal level and goes lower or even negative, it indicates some of stocks have deviated from the normal direction of the group. The deviation could reverse if long term level of correlation was at a higher level. It creates trading opportunities and deserves study whether the deviation is idiosyncratic or systematic.
Among pairwise correlation, the highest correlation is 93.0% between POTX and THCX
The lowest correlation is -16.9% between CNBS and HEXO
CANACA Introduces New Flower Offerings and Infused Pre-roll LineupTORONTO, Sept. 29, 2023 (GLOBE NEWSWIRE) -- Tilray Brands, Inc. ("Tilray" or the "Company") (Nasdaq: TLRY; TSX: TLRY), a leading global cannabis and consumer packaged goods company, today announced the launch of its expanded product lineup by its quintessentially Canadian cannabis lifestyle brand, CANACA. Introducing its new ‘Let ‘Er Rip’ Campaign, a curated collection of products crafted to elevate intensity while offering flavou
SNDL Inc. (NASDAQ: SNDL) ("SNDL") and Nova Cannabis Inc. (TSX: NOVC) ("Nova") announced today that while all other provincial approvals have been received, the continued review by one provincial regulator has necessitated a further extension of the outside date for the closing of the previously-announced strategic partnership (the "Transaction"). SNDL and Nova anticipate that the Transaction will close on or before October 30, 2023, subject to receipt of regulatory approval.
Cannabis legislation might be nearing a milestone. If passed through Congress, the SAFER Banking Act could give registered cannabis businesses access to small business loans and various financial protections. Poseidon (PSDN) Co-Founder and Managing Partner Emily Paxhia joins Yahoo Finance Live and notes that this is the first time the SAFER Banking Act has made a run through the Senate, but expresses concerns that it “might not be a priority” for House lawmakers amid the approaching 2024 electio...
Canadian cannabis producer Tilray is expanding its product base and improving its bottom line. With new acquisitions and the stock off its 52-week low, is TLRY stock a bargain buy now? Schedule 1 drugs include heroin and LSD and are said to have "no currently accepted medical use and a high potential for abuse," as defined by the U.S. Drug Enforcement Administration.
TORONTO, September 26, 2023--Organigram Holdings Inc. (NASDAQ: OGI) (TSX: OGI), (the "Company" or "Organigram"), a leading licenced producer of cannabis, announced today that it has filed a preliminary short form base shelf prospectus (the "Base Shelf Prospectus") with the securities commissions in each of the provinces and territories of Canada. A corresponding shelf registration statement on Form F-10 (the "Registration Statement") has been filed with the United States Securities and Exchange
Key Insights The projected fair value for Tilray Brands is US$4.62 based on 2 Stage Free Cash Flow to Equity Current...
Diversification is part of Tilray's goal, but all roads inevitably lead back to trying to take advantage of the U.S. cannabis market -- if and when it eventually opens up.
Calliditas Therapeutics AB Sponsored ADR (CALT) witnessed a jump in share price last session on above-average trading volume. The latest trend in earnings estimate revisions for the stock doesn't suggest further strength down the road.
Cannabis stocks soared as rescheduling news made waves this month. The Department of Health and Human Services recommended moving the plant from Schedule I to III. Rescheduling opens new vistas for the cannabis industry, including much-needed tax advantages. Likewise, congressional researchers affirmed last week that the Drug Enforcement Agency will likely follow the rescheduling recommendation. Of course, we’ve been on the cusp of legalization for years. Cannabis companies had their heyday in t
NEW YORK and LEAMINGTON, Ontario, Sept. 21, 2023 (GLOBE NEWSWIRE) -- Tilray Brands, Inc. (“Tilray” or the “Company”) (Nasdaq: TLRY; TSX: TLRY), a leading global cannabis-lifestyle and consumer packaged goods company, today announced that the Company will release financial results for its first quarter ended August 31, 2023 on October 4, 2023. Live Audio Webcast Tilray will host a live audio webcast to discuss these results at 8:30 am Eastern Time, which can be accessed on the Investors section o